Skip to content

Clinical Evaluation Of An X-Ray Bone Densitometer:Use Of DXA Technology For Precise Assessment Of Human Body Composition

Clinical Evaluation Of An X-Ray Bone Densitometer: Use Of DXA Technology For Precise Assessment Of Body Composition In Humans

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02965742
Enrollment
50
Registered
2016-11-17
Start date
2016-02-29
Completion date
2020-01-31
Last updated
2019-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteodensitometry

Keywords

DXA, DMS, DMS Imaging, STRATOS, Horizon A, QDR4500A

Brief summary

The main objectives of this study are: * to assess the concordance of body composition measures between two bone densitometry devices: the STRATOS by Diagnostic Medical Systems (DMS) and the Hologic QDR 4500 A by Hologic inc. * to assess the concordance of body composition measures between two bone densitometry devices: the STRATOS by Diagnostic Medical Systems (DMS) and the Hologic HORIZON A by Hologic inc.

Detailed description

The secondary objectives of this study are: * the assessment of the consistency of body composition measurements at local level (arms, trunk, legs) between the Stratos and Hologic 4500 A, * the assessment of the consistency of body composition measurements at local level (arms, trunk, legs) between the Stratos and Hologic HORIZON A, * Monitoring the evolution of body composition in patients receiving at least two evaluations of DXA Hologic QDR 4500A on: patients treated for obesity or anorexia nervosa, sports people and other patient with prescription DXA and the assessment the consistency of body composition measurements in terms, * Monitoring the evolution of body composition in patients receiving at least two evaluations of DXA Hologic HORIZON A on: patients treated for obesity or anorexia nervosa, sports people and other patient with prescription DXA and the assessment the consistency of body composition measurements in terms.

Interventions

DEVICEHologic HORIZON A

A machine made by Hologic inc.

DEVICEHologic QDR 4500A

A machine made by Hologic inc.

DEVICEStratos

A machine made by DMS group.

Sponsors

Diagnostic Medical Systems
Lead SponsorINDUSTRY
University Hospital, Montpellier
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is referred by a doctor for the performance of an osteodensitometry examination or sportsmen coming through a protocol where the nuclear medicine department is the investigator center

Exclusion criteria

* The patient is pregnant or nursing * The patient is unable to sign or refuse to sign the informed consent * The patient has a coronary stent or metal sutures in the heart * The patient has any type of metal objects in the body such as an artificial joint, a pin or a metal plate * The patient has a pacemaker or defibrillator * Patient weighing more than 200 kg or more than 2 meters high by 65 centimeters wide * The patient is using an insulin pump or with insulin-necked * The patient has undergone X-ray examination using a contrast medium such as barium in the previous seven days visit, * Patient who underwent an examination using x rays in the 15 days preceding the visit * Patient suffering from generalized edema

Design outcomes

Primary

MeasureTime frameDescription
Lin concordance coefficientDay 0In order to get a first idea of the adequacy of the two techniques measurements of the two bone densitometers, a calculation of intraclass correlation coefficients will be done. To supplement this data, a correlation study between the two techniques will be performed. For this we will use the Bland-Altman technique and a study of LIN concordance correlation coefficient

Countries

France

Contacts

Primary ContactLaurent MAIMOUN, Phd.
l-maimoun@chu-montpellier.fr0467338464
Backup ContactSana EL OUAZGHARI, Bsc.
selouazghari@dms-imaging.com0466271059

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026